Gilead already made a $425 million equity investment in Galapagos by subscribing for shares at a price of €58 per share on December 17, 2015. On July 14, 2019 Gilead’s equity investment will consis...
Bryan Garnier Co Morphosys (Buy) PT Under Review(7th August 2019)Next Catalyst : Meet the Management (London, September 10th)MOR208: Acceleration of European filing and disclosure of B-MIND’s biom...
Cowen and Company Biotech Thermometer (Augustus 2019)Stocks Most Loved By The Buyside: GLPGPhil Nadeau from Cowen Co. maintained a Buy rating on Galapagos NV.
UBS 31 July 2019, Laura SutcliffeToledo is generating interest among investors and data is due in 2H.Galapagos has discovered a novel target in inflammatory disease and is developing several potent...
@ Pl4 KomMaarDoorIt was published in the latest analyst Nomura Instinet Report.
Thieu Vaessen FDVijf miljard euro in kas vind ik geen probleemBiotechbedrijf Galapagos ontvangt binnenkort €4,5 mrd van het Amerikaanse farmabedrijf Gilead en heeft dan €5,5 mrd in kas. Wat moet he...
Bryan Garnier Co Galapagos (Buy) PT EUR 180 (15th July 2019)USD 5.1bn right of first review on Galapagos existing and future pipeline.
Thanks again for your work Dar-win!Posted this in another thread on the 16th of July:Dharminder Chahal on Linkedin:Congratulations to Galapagos on behalf of Van Herk Groep. A unique landmark deal. ...
It is all about innovation. Onnos view on the collaboration with Gileadwww.youtube.com/watch?v=mrTTfYIUDVA
@winx09www.africanparks.org/donate
Technical analysis trends GALAPAGOS NV (ADR)Trend: BullishNext Target $ 145
In its Q3 call, Gilead indicated contemplating to discuss with the FDA thepossibility of a rolling submission, i.e. filling MANTA later than clinical RAdata (n.b. the submission will still require ...
Because of all the crap on this thread are first post and hint before the FINCH-2 data came out only got picked up by Piddybull. So shout out to you.In are first post we forgot to mention Lama Dail...
We expect Gilead to present topline results of the FINCH-2 study set at the next ACR conference, 19th-24th October 2018Shout out to: Biotech Radar, pe26, Volker Schulz, BioStockAddict, NielsjeB, Vo...